Velosef Antibiotic Medication for Bacterial Infections

Velosef is an antibiotic medication belonging to the cephalosporin class used to treat bacterial infections like respiratory tract infections, urinary tract infections, and skin infections.
Category
Medication
Where to get
Available by prescription in pharmacies.
Prepared by Shruti Sahoo, reviewed by Dr. Eugene Smith

Velosef FAQ


Image credit: almishkat.pk

Can velosef be used to treat bacterial infections?

Medically reviewed by Drugs.com. Last updated on Mar 27, 2023. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Velosef and other antibacterial drugs, Velosef should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

How does velosef work?

Velosef is a first generation cephalosporin antibiotic that works in a similar way to penicillin by inhibiting bacterial cell wall synthesis. It has a broad spectrum bactericidal activity against both gram-positive and gram-negative bacteria.

Is velosef a cephalosporin?

Velosef is a first generation cephalosporin antibiotic with a spectrum of activity similar to Cefalexin. Velosef, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis.

Is velosef (cephradine) acid stable?

Velosef (Cephradine) is acid stable. It is rapidly absorbed after oral administration in the fasting state. Following single doses of 250 mg, 500 mg, and 1 g in normal adult volunteers, average peak serum concentrations within one hour were approximately 9 mcg/mL, 16.5 mcg/mL, and 24.2 mcg/mL, respectively.

Velosef References

If you want to know more about Velosef, consider exploring links below:

Explore Related Topics

What are the emerging trends in antimicrobial susceptibility testing methods?

Explore the latest developments and advancements in antimicrobial susceptibility testing, including genotypic methods, MALDI-TOF mass spectrometry, and rapid molecular techniques. Discuss the potential impact of these novel approaches on enhancing the speed and accuracy of identifying antibiotic-resistant pathogens.